Alisaca, Shane .

HRN: 21-05-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
AMPICILLIN 1GM (VIAL)
03/14/2026
03/20/2026
IV
625mg
Q6
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: